EQ compared with PMN: revenue, margins and what each company keeps, and the suppliers and customers both name

EQEquillium, Inc.

Mkt capRevenueRevenue

PMNProMIS Neurosciences Inc.

Mkt capRevenueRevenue

Compare

EQEquillium, Inc.

PMNProMIS Neurosciences Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

EQ1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±25.7%▲+17.41%×0.68

PMN1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+0.47%—

= impliedEQ realized, solidPMN realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedSource: market data

EQEquillium, Inc.

1.43▲+3.72%

Mkt cap$86.9MRevenue$4MQ4 FY24Revenue$41MFY24

PMNProMIS Neurosciences Inc.

3.33▲+10.95%

Regular sessionNov 3 '26

Mkt cap$26.9MRevenue—Revenue—

Compare

Regular sessionNov 3 '26

EQEquillium, Inc.

PMNProMIS Neurosciences Inc.

1.43▲+3.72%

Price

3.33▲+10.95%

$86.9M

Mkt cap

$26.9M

Q4 FY24$4M

Revenue

—

FY24$41M

Revenue

—

EQ1.43▲+3.72%vsPMN3.33▲+10.95%Regular sessionNov 3 '26